Abbott Laboratories Stock Performance
| ABT Stock | USD 112.68 1.21 1.09% |
The firm shows a Beta (market volatility) of 0.31, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Abbott Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding Abbott Laboratories is expected to be smaller as well. At this point, Abbott Laboratories has a negative expected return of -0.21%. Please make sure to confirm Abbott Laboratories' treynor ratio, and the relationship between the standard deviation and kurtosis , to decide if Abbott Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Abbott Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 1.09 | Five Day Return 2.34 | Year To Date Return (9.27) | Ten Year Return 196.6 | All Time Return 68.3 K |
Forward Dividend Yield 0.0224 | Payout Ratio | Forward Dividend Rate 2.52 | Dividend Date 2026-02-13 | Ex Dividend Date 2026-01-15 |
| Abbott Laboratories dividend paid on 17th of November 2025 | 11/17/2025 |
1 | Saxon Interests Inc. Has 1.83 Million Stock Holdings in AbbVie Inc. ABBV | 01/27/2026 |
2 | Abbott receives FDA warning letter related to FreeStyle Libre CGMs | 02/03/2026 |
3 | DexComs CEO Believes Diabetics On GLP-1s Should Also Wear CGMs | 02/05/2026 |
4 | Drug of Abuse Testing Market Expands Across APAC, Europe, USA, and Saudi Arabia with Rising Workplace Clinical Screening | 02/06/2026 |
5 | Senators stock trades directly overlapped with their committee work, analysis finds | 02/09/2026 |
6 | Compagnie Lombard Odier SCmA Sells 3,902 Shares of AbbVie Inc. ABBV | 02/10/2026 |
7 | Stratos Wealth Partners LTD. Purchases 10,346 Shares of AbbVie Inc. ABBV | 02/11/2026 |
8 | Abbott Labs The Healthcare Dividend Stock Id Happily Hold Forever | 02/12/2026 |
| Abbott Laboratories dividend paid on 13th of February 2026 | 02/13/2026 |
| Begin Period Cash Flow | 6.9 B | |
| Total Cashflows From Investing Activities | -2.3 B |
Abbott Laboratories Relative Risk vs. Return Landscape
If you would invest 12,937 in Abbott Laboratories on November 16, 2025 and sell it today you would lose (1,669) from holding Abbott Laboratories or give up 12.9% of portfolio value over 90 days. Abbott Laboratories is generating negative expected returns assuming volatility of 1.7526% on return distribution over 90 days investment horizon. In other words, 15% of stocks are less volatile than Abbott, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Abbott Laboratories Target Price Odds to finish over Current Price
The tendency of Abbott Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 112.68 | 90 days | 112.68 | about 87.92 |
Based on a normal probability distribution, the odds of Abbott Laboratories to move above the current price in 90 days from now is about 87.92 (This Abbott Laboratories probability density function shows the probability of Abbott Stock to fall within a particular range of prices over 90 days) .
Abbott Laboratories Price Density |
| Price |
Predictive Modules for Abbott Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Abbott Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Abbott Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Abbott Laboratories is not an exception. The market had few large corrections towards the Abbott Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Abbott Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Abbott Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.17 | |
β | Beta against Dow Jones | 0.31 | |
σ | Overall volatility | 7.25 | |
Ir | Information ratio | -0.13 |
Abbott Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Abbott Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Abbott Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Abbott Laboratories generated a negative expected return over the last 90 days | |
| Over 82.0% of the company shares are held by institutions such as insurance companies | |
| On 13th of February 2026 Abbott Laboratories paid $ 0.63 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Abbott Labs The Healthcare Dividend Stock Id Happily Hold Forever |
Abbott Laboratories Fundamentals Growth
Abbott Stock prices reflect investors' perceptions of the future prospects and financial health of Abbott Laboratories, and Abbott Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abbott Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0679 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 199.04 B | ||||
| Shares Outstanding | 1.74 B | ||||
| Price To Earning | 24.14 X | ||||
| Price To Book | 3.80 X | ||||
| Price To Sales | 4.42 X | ||||
| Revenue | 44.33 B | ||||
| Gross Profit | 25.14 B | ||||
| EBITDA | 11.33 B | ||||
| Net Income | 13.4 B | ||||
| Cash And Equivalents | 7.62 B | ||||
| Cash Per Share | 5.68 X | ||||
| Total Debt | 15.28 B | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 1.86 X | ||||
| Book Value Per Share | 29.30 X | ||||
| Cash Flow From Operations | 8.56 B | ||||
| Earnings Per Share | 3.72 X | ||||
| Market Capitalization | 196.11 B | ||||
| Total Asset | 81.41 B | ||||
| Retained Earnings | 47.26 B | ||||
| Working Capital | 9.5 B | ||||
| Current Asset | 14.15 B | ||||
| Current Liabilities | 9.19 B | ||||
About Abbott Laboratories Performance
Assessing Abbott Laboratories' fundamental ratios provides investors with valuable insights into Abbott Laboratories' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Abbott Laboratories is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 126.06 | 110.88 | |
| Return On Tangible Assets | 0.30 | 0.17 | |
| Return On Capital Employed | 0.12 | 0.11 | |
| Return On Assets | 0.19 | 0.13 | |
| Return On Equity | 0.32 | 0.26 |
Things to note about Abbott Laboratories performance evaluation
Checking the ongoing alerts about Abbott Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abbott Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Abbott Laboratories generated a negative expected return over the last 90 days | |
| Over 82.0% of the company shares are held by institutions such as insurance companies | |
| On 13th of February 2026 Abbott Laboratories paid $ 0.63 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Abbott Labs The Healthcare Dividend Stock Id Happily Hold Forever |
- Analyzing Abbott Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abbott Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Abbott Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abbott Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abbott Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abbott Laboratories' stock. These opinions can provide insight into Abbott Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.